SCHEMBL296699

SCHEMBL296699

CC(C)CCOC(=O)CC(O)C(=O)OCCC(C)C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.44
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPK1 P28482 3/20 0.36
PKM P14618 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.35
EPHX2 P34913 1/20 0.34
ACHE P22303 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
PPARG P37231 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21409612 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL15698 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL3285309 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL14674414 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL29929707 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL14673679 0.85 NAAA (0.43) CYP19A1MAPK1L3MBTL1
SCHEMBL28774174 0.85 GABRP (0.36) CYP19A1
SCHEMBL28774169 0.85 GABRP (0.36) CYP19A1
SCHEMBL21436836 0.84 SMN1; SMN2 (0.43) CYP19A1CA12CA1CA2CA9
SCHEMBL27561706 0.84 CYP19A1 (0.39) CYP19A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116268007-B Room-temperature volatile mosquito repellent liquid and preparation method thereof 湖南雪天精细化工股份有限公司 2025-04-22 CN claimed
WO-2024074708-A1 STABLE DISPERSIONS OF TITANIUM DIOXIDE AND/OR ZINC OXIDE OLEON NV (BE) 2024-04-11 WO claimed
EP-4349317-A1 STABLE DISPERSIONS OF TITANIUM DIOXIDE AND/OR ZINC OXIDE Oleon N.V. (BE) 2024-04-10 EP claimed
CN-102123764-B Hydroalcoholic gel compositions for use with dispensers GOJO IND INC 2015-04-15 CN claimed
EP-2288416-B2 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2014-12-24 EP claimed
US-8822547-B2 Hydroalcoholic gel compositions for use with dispensers GOJO INDUSTRIES, INC. (US) 2014-09-02 US claimed
EP-2460560-A1 Hydroalcoholic gel compositions for use with dispensers Gojo Industries, Inc. (US) 2012-06-06 EP claimed
EP-2288416-B1 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2012-02-29 EP claimed
CN-102123764-A Hydroalcoholic gel compositions for use with dispensers GOJO IND INC 2011-07-13 CN claimed
US-20110144214-A1 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2011-06-16 US claimed
EP-2288416-A2 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO Industries, Inc. (US) 2011-03-02 EP claimed
WO-2009058802-A2 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO INDUSTRIES, INC. (US) 2009-05-07 WO claimed
EP-1663123-A2 SUNSCREEN OR MEDICINAL WIPES HAVING HIGH SUNSCREEN FORMULATION TRANSFER RATE Kimberly-Clark Worldwide, Inc. (US) 2006-06-07 EP claimed
EP-1490018-A2 SUNSCREEN COMPOSITIONS AND METHODS AND MATERIALS FOR PRODUCING THE SAME The C.P. Hall Company (US) 2004-12-29 EP claimed
WO-2004100914-A2 SUNSCREEN OR MEDICINAL WIPES HAVING HIGH SUNSCREEN FORMULATION TRANSFER RATE KIMBERLY-CLARK WORLDWIDE INC. (US) 2004-11-25 WO claimed
US-20040228811-A1 Sunscreen wipes having high sunscreen formulation transfer rate KIMBERLY-CLARK WORLDWIDE, INC. 2004-11-18 US claimed
WO-2003075877-A2 SUNSCREEN COMPOSITIONS AS WELL AS METHODS AND MATERIALS FOR PRODUCING THE SAME, WHEREIN THE PHOTODECAY RATE OF THE FILTER SYSTEM IS REDUCED BY CONTROLLING THE POLARITY OF THE SOLVENT SYSTEM THE C.P. HALL COMPANY (US) 2003-09-18 WO claimed
US-6485713-B1 CONTROLLING THE POLARITY OF A SOLVENT SYSTEM IN THE COMPOSITION TO CONTROL THE RATE OF PHOTODECAY OF A FILTER SYSTEM IN THE COMPOSITION THE C. P. HALL COMPANY 2002-11-26 US claimed
CN-116268007-B Room-temperature volatile mosquito repellent liquid and preparation method thereof 湖南雪天精细化工股份有限公司 2025-04-22 CN disclosed
US-6485713-B1 CONTROLLING THE POLARITY OF A SOLVENT SYSTEM IN THE COMPOSITION TO CONTROL THE RATE OF PHOTODECAY OF A FILTER SYSTEM IN THE COMPOSITION THE C. P. HALL COMPANY 2002-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144214-A1 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS ADH1A, ADH1C, ADH5 CYP19A1 1877/4885CA12 3879/4885CA1 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.